Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02VUX
|
|||
| Former ID |
DCL000595
|
|||
| Drug Name |
PF-217830
|
|||
| Synonyms |
PF-00217830; 7-[4-(4-naphthalen-1-ylpiperazin-1-yl)butoxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bipolar disorder [ICD-11: 6A60; ICD-10: F31] | Discontinued in Phase 2 | [1] | |
| Schizophrenia [ICD-11: 6A20] | Discontinued in Phase 2 | [1] | ||
| Company |
Pfizer
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H30N4O2
|
|||
| Canonical SMILES |
C1CC(=O)NC2=C1C=CC(=N2)OCCCCN3CCN(CC3)C4=CC=CC5=CC=CC=C54
|
|||
| InChI |
1S/C26H30N4O2/c31-24-12-10-21-11-13-25(28-26(21)27-24)32-19-4-3-14-29-15-17-30(18-16-29)23-9-5-7-20-6-1-2-8-22(20)23/h1-2,5-9,11,13H,3-4,10,12,14-19H2,(H,27,28,31)
|
|||
| InChIKey |
QGNOXTFZOLDODX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 846032-02-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025560) | |||
| REF 2 | Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.Curr Med Chem.2014;21(4):437-57. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.